CLYM
Climb Bio, Inc. Common Stock
CLYM
CLYM
43 hedge funds and large institutions have $146M invested in Climb Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+8
Holders Change %
+22.86%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
6
Reduced
19
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
